Acquired by LGC Biosearch Technologies. Developer of an automated spatial omics platform intended to analyze cells at the molecular level while maintaining spatial context. The company's platform combines a fully automated microfluidics setup for sequential labeling of expressed transcripts with sensitive and scalable high-resolution imaging, enabling pharmaceutical groups to visualize gene expression profiles across large areas of human brain tissue sections at remarkable speed and without compromising data quality.
Location: United States, California, Santa Clara
Total raised: $20M
Investors 2
| Date | Name | Website |
| - | Western Te... | westerntec... |
| - | Illumina V... | illuminaVe... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 29.11.2020 | Series B | $20M | - |
Mentions in press and media 4
| Date | Title | Description | Source |
| 19.01.2022 | Spatial Omics: The Next Wave in the Biological Research Revo... | Josh Ryu, Chief Technology Officer and Co-founder, Rebus Biosystems For decades, biomedical researc... | hitconsult... |
| 22.10.2021 | Veta Health Apoints CEO, Walgreens Leadership Appointments, ... | James Sutcliffe, CEO at Veta Health Veta Health, a global provider of digital solutions for remote ... | hitconsult... |
| 01.03.2021 | Rebus Biosystems Launches Automated Spatial Omics Platform | SANTA CLARA, Calif., March 1, 2021 /PRNewswire/ -- Rebus Biosystems, Inc., a life science technolo... | prnewswire... |
| 19.11.2020 | Rebus Biosystems, Inc. Announces $20 Million Series B Financ... | SANTA CLARA, Calif., Nov. 19, 2020 /PRNewswire/ -- Rebus Biosystems, Inc., a life science technolo... | prnewswire... |